180 related articles for article (PubMed ID: 1787383)
1. Thrombosis and hemorrhage in thrombocytosis: evaluation of a large cohort of patients (357 cases).
Randi ML; Stocco F; Rossi C; Tison T; Girolami A
J Med; 1991; 22(4-5):213-23. PubMed ID: 1787383
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of specific thrombotic accidents in patients with thrombocytosis.
Randi ML; Fabris F; Tison T; Barbone E; Rossi C; Girolami A
Haematologia (Budap); 1993; 25(3):149-52. PubMed ID: 8119627
[TBL] [Abstract][Full Text] [Related]
3. Sex and age as prognostic factors in essential thrombocythemia.
Randi ML; Fabris F; Rossi C; Tison T; Barbone E; Girolami A
Haematologica; 1992; 77(5):402-4. PubMed ID: 1483589
[TBL] [Abstract][Full Text] [Related]
4. Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications.
Michiels JJ; Berneman Z; Van Bockstaele D; van der Planken M; De Raeve H; Schroyens W
Semin Thromb Hemost; 2006 Apr; 32(3):174-207. PubMed ID: 16673274
[TBL] [Abstract][Full Text] [Related]
5. Etiology and incidence of thrombotic and hemorrhagic disorders in Thai patients with extreme thrombocytosis.
Chuncharunee S; Archararit N; Ungkanont A; Jootar S; Angchaisuksiri P; Bunyaratavej A; Rojanasthein S; Atichartakarn V
J Med Assoc Thai; 2000 Mar; 83 Suppl 1():S95-100. PubMed ID: 10865414
[TBL] [Abstract][Full Text] [Related]
6. Polycythemia vera and essential thrombocythemia in young patients.
Frezzato M; Ruggeri M; Castaman G; Rodeghiero F
Haematologica; 1993; 78(6 Suppl 2):11-7. PubMed ID: 8039752
[TBL] [Abstract][Full Text] [Related]
7. [Vascular complications of essential thrombocythemia].
Bellucci S
Bull Acad Natl Med; 2007 Mar; 191(3):519-30; discussion 530-3. PubMed ID: 18072651
[TBL] [Abstract][Full Text] [Related]
8. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.
De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Gerli G; Vianelli N; Guglielmelli P; Pieri L; Scognamiglio F; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Marchioli R; Leone G; Barbui T;
Haematologica; 2008 Mar; 93(3):372-80. PubMed ID: 18268279
[TBL] [Abstract][Full Text] [Related]
9. Splenectomy after portal thrombosis in patients with polycythemia vera and essential thrombocythemia.
Randi ML; Fabris F; Ruzzon E; Pacquola E; Cella G; Girolami A
Haematologica; 2002 Nov; 87(11):1180-4. PubMed ID: 12414348
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic dilemmas: balancing the risks of bleeding, thrombosis, and leukemic transformation in myeloproliferative disorders (MPD).
Murphy S
Thromb Haemost; 1997 Jul; 78(1):622-6. PubMed ID: 9198227
[TBL] [Abstract][Full Text] [Related]
11. Reduction of antithrombin III, protein C, and protein S levels and activated protein C resistance in polycythemia vera and essential thrombocythemia patients with thrombosis.
Bucalossi A; Marotta G; Bigazzi C; Galieni P; Dispensa E
Am J Hematol; 1996 May; 52(1):14-20. PubMed ID: 8638606
[TBL] [Abstract][Full Text] [Related]
12. Incidence and clinical risk factors for bleeding and thrombotic complications in myeloproliferative disorders. A retrospective analysis of 260 patients.
Wehmeier A; Daum I; Jamin H; Schneider W
Ann Hematol; 1991 Aug; 63(2):101-6. PubMed ID: 1912029
[TBL] [Abstract][Full Text] [Related]
13. [Clinical analysis of 438 patients with essential thrombocythemia].
Lan HF; Fang ZH; Zhang Y; Wang XY; Xue F; Zhang L; Guo ZX; Dong XW; Li SZ; Zheng YZ; Zhang FK; Qian LS; Ji LX; Xiao ZJ; Yang RC
Zhonghua Xue Ye Xue Za Zhi; 2008 Sep; 29(9):587-91. PubMed ID: 19175983
[TBL] [Abstract][Full Text] [Related]
14. Erythromelalgic, thrombotic and hemorrhagic manifestations in 50 cases of thrombocythemia.
Michiels JJ; van Genderen PJ; Lindemans J; van Vliet HH
Leuk Lymphoma; 1996 Sep; 22 Suppl 1():47-56. PubMed ID: 8951772
[TBL] [Abstract][Full Text] [Related]
15. The haematocrit and platelet target in polycythemia vera.
Di Nisio M; Barbui T; Di Gennaro L; Borrelli G; Finazzi G; Landolfi R; Leone G; Marfisi R; Porreca E; Ruggeri M; Rutjes AW; Tognoni G; Vannucchi AM; Marchioli R;
Br J Haematol; 2007 Jan; 136(2):249-59. PubMed ID: 17156406
[TBL] [Abstract][Full Text] [Related]
16. The role of platelets in the pathogenesis of thrombosis and hemorrhage in patients with thrombocytosis.
Walsh PN; Murphy S; Barry WE
Thromb Haemost; 1977 Dec; 38(4):1085-96. PubMed ID: 579686
[TBL] [Abstract][Full Text] [Related]
17. Characteristic changes in platelet-large cell ratio, lactate dehydrogenase and C-reactive protein in thrombocytosis-related diseases.
Kabutomori O; Kanakura Y; Iwatani Y
Acta Haematol; 2007; 118(2):84-7. PubMed ID: 17622783
[TBL] [Abstract][Full Text] [Related]
18. The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera.
Michiels JJ; Berneman Z; Schroyens W; Finazzi G; Budde U; van Vliet HH
Semin Thromb Hemost; 2006 Sep; 32(6):589-604. PubMed ID: 16977569
[TBL] [Abstract][Full Text] [Related]
19. Arterial stenosis and atherothrombotic events in polycythemia vera and essential thrombocythemia.
Cucuianu A; Stoia M; Farcaş A; Dima D; Zdrenghea M; Paţiu M; Olinic D; Petrov L
Rom J Intern Med; 2006; 44(4):397-406. PubMed ID: 18386616
[TBL] [Abstract][Full Text] [Related]
20. Template bleeding time and clinical hemorrhage in myeloproliferative disease.
Murphy S; Davis JL; Walsh PN; Gardner FH
Arch Intern Med; 1978 Aug; 138(8):1251-3. PubMed ID: 277084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]